<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ivy</surname>
    <given-names>SP</given-names>
   </name>
   <name>
    <surname>Kunos</surname>
    <given-names>CA</given-names>
   </name>
   <name>
    <surname>Arnaldez</surname>
    <given-names>FI</given-names>
   </name>
   <name>
    <surname>Kohn</surname>
    <given-names>EC</given-names>
   </name>
  </person-group>
  <article-title>Defining and targeting wild-type BRCA high-grade serous ovarian cancer: DNA repair and cell cycle checkpoints</article-title>
  <source>Expert Opin Investig Drugs</source>
  <year>2019</year>
  <volume>28</volume>
  <fpage>771</fpage>
  <lpage>785</lpage>
  <pub-id pub-id-type="doi">10.1080/13543784.2019.1657403</pub-id>
  <?supplied-pmid 31449760?>
  <pub-id pub-id-type="pmid">31449760</pub-id>
 </element-citation>
</ref>
